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Abstract
Background: There are limited data on the prevalence and approaches to screening for depression among
pregnant women living in resource poor settings with high HIV burden.
Methods: We studied the reliability and accuracy of the Center for Epidemiologic Studies Depression (CES-D) scale
in 123 (36 HIV-infected and 87 -uninfected) pregnant women receiving antenatal care at Gulu Regional Referral
Hospital, Uganda. CES-D scores were compared to results from the psychiatrist-administered Mini-International
Neuropsychiatric Interview (MINI) for current major depressive disorder (MDD), a “gold standard” for assessing
depression. We employed measures of internal consistency (Cronbach’s alpha), and criterion validity [Area Under
the Receiver Operating Characteristic Curve (AUROC), sensitivity (Se), specificity (Sp), and positive predictive value
(PPV)] to evaluate the reliability and validity of the CES-D scale.
Results: 35.8% of respondents were currently experiencing an MDD, as defined from outputs of the MINI-depression
module. The CES-D had high internal consistency (Cronbach’s alpha = 0.92) and good discriminatory ability in detecting
MINI-defined current MDDs (AUROC = 0.82). The optimum CES-D cutoff score for the identification of probable MDD
was between 16 and 17. A CES-D cutoff score of 17, corresponding to Se, Sp, and PPV values of 72.7%, 78.5%, and
76.5%, is proposed for adoption in this population and performs well for HIV-infected and -uninfected women. After
adjusting for baseline differences between the HIV subgroups (maternal age and marital status), HIV-infected
pregnant women scored 6.2 points higher on the CES-D than HIV-uninfected women (p = 0.032).
Conclusions: The CES-D is a suitable instrument for screening for probable major depression among pregnant women
of mixed HIV status attending antenatal services in northern Uganda.
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Background
Since the first Global Burden of Disease (GBD) report was
released in 1996 [1], the impacts that HIV infection and
major depressive disorders (MDDs) have had on medical
and public health systems have greatly increased. The
2010 GBD report indicated that HIV infection has risen
from being the 33rd to the 5th contributor to the global
burden of disease, while MDDs have risen from being the
15th leading cause to being the 11th [2]. While there has
been a surge of information and strategies for managing
or preventing HIV infection, practical strategies for man-
aging MDDs remain limited, particularly in resource poor
settings.
In Sub-Saharan Africa (SSA), the reported prevalence
of MDDs among adult people living with HIV (PLHIV)
ranges broadly, from 71.3% in Zambia [3] to 47% in
Uganda [4], 43.7% in South Africa [5], and 30% in
Zimbabwe [6]. A number of biological and psychosocial
factors and psychiatric co-morbidities help explain why
persons with HIV are at a higher risk of depression [7].
Moreover, depression has been associated with increased
rates of HIV disease progression and mortality [8], in-
equity in decision-making and relationship power among
heterosexual couples [9], and AIDS-related stigma [10].
Reports indicate that as many as 30% of PLHIV develop
MDDs during the course of their illness [11,12]. The
majority of studies reporting the prevalence or incidence
of depressive symptoms among PLHIV in SSA have not
compared rates among PLHIV to those among HIV-
negative persons. Both depression [13-15] and HIV [7,16]
disproportionately affect more women than men. Limited
data from SSA settings [17] and recent data from the US
[18] have examined the cross-sectional linkage between
maternal HIV infection and depression prevalence during
pregnancy. No study has examined the differences in the
trajectory of depressive symptoms among HIV-infected
and -uninfected pregnant women. In the sole cross-
sectional study that compared the prevalence of depres-
sive symptoms among newly tested HIV-positive and
HIV-negative pregnant women in South Africa, no asso-
ciation between HIV infection status and depressive
symptoms severity was found [17]. A similar result of no
difference in depressive symptoms by HIV serostatus was
reported for US women attending an obstetrics/gynecology
clinic in urban Philadelphia [18]. It is, therefore, unclear
whether the prevalence or incidence of major depression
or depressive symptoms differs between HIV-infected
and -uninfected pregnant women in SSA. Integrating
screening, referral, and treatment for major depression
into programs targeting HIV-infected and -uninfected
pregnant women in SSA could help fill this gap.
Screening for depression among pregnant women is of
specific interest, because this would facilitate early detec-
tion of depressive symptoms and the referral and treatment
of women with probable major depression. Depression
may affect pregnant women’s functionality, capacity to
care for themselves, and ability to utilize household and
community level resources. Depressed women may not be
able to (1) acquire and prepare food, (2) attend antenatal
care (ANC) services, and, for those that are HIV positive,
(3) utilize services aimed at preventing mother to child
transmission of HIV (PMTCT). Depression during preg-
nancy is a risk factor for postnatal depression [19] and may
have direct [20] or indirect (through its influence on
postnatal depression; [21]) impacts on mother-child inter-
actions and the infants’ emotional and behavioral develop-
ment. It is important that pregnant women with or at risk
of depression are screened and appropriately treated before
it becomes too late to intervene. Antenatal care (ANC)
clinics in regional, district, and lower level health centers in
resource poor settings, such as northern Uganda, provide
potential entry points for screening, referral and treatment
of pregnant women with or at risk of depression.
In order to appropriately identify pregnant women with
or at risk of depression, there is a need for a reliable and
valid screening tool. A recent review of depression screen-
ing tools used in low and middle-income countries did
not recommend any specific instrument [22]. The Center
for Epidemiologic Studies-Depression (CES-D) [23] is an
attractive screening tool for depression because it covers
all of the common symptoms of major depression, i.e. de-
pressive mood, feelings of guilt and worthlessness, psycho-
motor retardation, loss of appetite, and sleep disturbance.
The CES-D consists of 20 items that are designed to
measure self-reported depressive symptoms in the prior
two weeks. Each of the 20 items is assigned a value of
0–3, with four items positively worded and reverse scored.
The total score is computed by summing the 20 items,
such that the range of scores is 0 to 60. A score of ≥16 in
the general US population is used to suggest the presence
of probable MDD. Elsewhere, the cutoff will vary based on
the prevalence of each of the 20 items in the population of
interest, the method of the scale’s administration (whether
as a self report or interviewer administered), and the ex-
tent of adaptation (e.g. translation into another language
before administration) that goes into making the CES-D
contextually relevant. Hence, it is important that the scale
be validated before it is used in new populations.
Within SSA the CES-D has been validated among
adult populations in Zambia [3] and South Africa [5] by
comparing results of the CES-D to those obtained using
a ‘gold standard’ for depression assessment, the depres-
sion module of the Mini-International Neuropsychiatric
Interview (MINI-D). The MINI (and the MINI-D com-
ponent as well) is a short, structured diagnostic interview
that was developed in 1990 by psychiatrists and clinicians
in the United States and Europe for DSM-IV psychiatric
disorders [24].
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Although the CES-D has been used among PLHIV in
Uganda [4,25] we did not find studies documenting the
scales validity in this context. Furthermore, these two
studies were conducted among HIV-infected adults only,
making it difficult to compare findings from such popula-
tions to those of HIV-uninfected populations. Thus, the
aim of this study was to assess the reliability and validity of
the CES-D as a relatively simple screening tool for probable
major depression among HIV-infected and -uninfected
pregnant women in northern Uganda.
Methods
Design, setting and participants
Data were collected from the 10th of October 2012 to
the 21st of December 2012, within the context of the
Prenatal Nutrition and Psychosocial Health Outcomes
(PreNAPs) study. The PreNAPs study is a longitudinal
observational study that seeks to describe the preva-
lence and trajectory of depressive symptoms among
HIV-infected and -uninfected pregnant women attend-
ing ANC services in northern Uganda.
HIV-infected and -uninfected participants were con-
secutively and separately recruited from the ANC clinic
of Gulu Regional Referral Hospital (GRRH) in Gulu,
northern Uganda, a busy primary care clinic that re-
ceives more than 400 initial antenatal visits monthly. As
at other public medical facilities in Uganda, all services
at GRRH, including medications, care for pregnant
women with HIV, etc., are offered free of charge. Con-
sistent with Ugandan national policy, all HIV-infected
women received prophylactic ARVs.
HIV-infected and -uninfected pregnant women who pre-
sented at ANC between 10 and 26 weeks of gestation and
resided within 30 km of GRRH were invited to participate.
HIV infected women were oversampled to achieve a mini-
mum ratio of 1 HIV infected: 2 HIV uninfected participants,
thus our sample has a higher proportion of HIV infected
women than the 10.3% age adjusted prevalence of HIV pre-
viously observed at ANC clinics in northern Uganda [26].
Data collection
All study instruments were translated by local research staff
into Acholi and Langi, the two predominant and closely
related Luo languages that are spoken in the study commu-
nities. The questionnaires were then back-translated into
English by the same team, and discrepancies in conceptual
and semantic equivalence were resolved through discussion
involving all the translators, the research assistants, and the
GRRH psychiatrist (TOO).
Maternal HIV status was determined at the ANC clinic
based on the Ugandan government’s HIV counseling and
testing guidelines [27] and prior to enrollment into this
study. Gestational age at recruitment was based on first
day of the last month of menstrual period. Wealth was
operationalized based on the pregnant women’s report of
their total household income divided by the number of
household members.
The CES-D was administered by members of the
PreNAPs study team (either a nutritionist, midwife, or
general nurse) after baseline health and demographics data
had been collected. Then, on the same day, respondents
underwent a diagnostic interview by the GRRH psy-
chiatrist (TOO), who was blinded to the results of the
CES-D screening interview, using the MINI-D.
One hundred and thirty-five consecutive pregnant
women were approached to participate in the MDD sub-
study of PreNAPs, and 125 (92.6%) consented to partici-
pate. Ten participants did not participate in the study
upon request due to “lack of time.” Of the 125 participants
who agreed to take part in the study, two had incomplete
survey data and were excluded from the final analysis; the
rest (n = 123, 36 HIV-infected and 87 HIV-uninfected)
participated in both the CES-D and MINI-D interviews.
Analysis
Data were analyzed using STATA version 12 (StataCorp
LP, College Station, TX). We compared HIV-infected
and -uninfected pregnant women with regard to mea-
sured baseline demographic and socioeconomic variables.
To test for baseline differences between HIV -infected and
-uninfected pregnant women, we used Pearson’s chi-
squared test for categorical variables, Student’s t-tests, and
the nonparametric equality-of-medians test for continuous
variables. Study participants were categorized into cases
and non-cases of currently experiencing a MDD based on
the MINI-D module outputs. Median total scores on the
CES-D were then compared against the MINI-D diagno-
ses of current MDD using the Wilcoxon rank-sum test.
We fit a linear regression model, adjusting for baseline
correlates of maternal HIV infection status, to determine
differences in baseline CES-D scores between HIV-
infected and -uninfected pregnant women.
We assessed the reliability of the CES-D scale using
the Cronbach’s test for internal consistency. Cronbach’s
alpha coefficients of 0.7 or greater were considered to
be reliable [28]. We determined the criterion validity of
the CES-D, i.e. the extent to which measurements
obtained using the CES-D concurred with those de-
termined with an established diagnostic test or gold
standard [29], by comparing scores on the CES-D
with psychiatrist administered MINI-D outputs. Further,
we used a non-parametric method, Area Under the
Receiver Operating Characteristic Curve (AUROC) ana-
lysis, to test the CES-D’s criterion validity. We selected
the optimum CES-D cutoff scores that concurrently
maximized sensitivity (Se), specificity (Sp) and positive
predictive values (PPV) when compared to the psy-
chiatrist administered MINI-D assessment.
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Results
Characteristics of the study participants
Characteristics of the studied sample are presented in
Table 1. HIV-infected and -uninfected women did not
differ in terms of their gestational age at assessment, the
predominant language they spoke, level of education,
occupation, or monthly household income per capita.
HIV-infected participants were 3.2 years older (p = 0.001)
and 21.9% less likely to be in a married or cohabiting rela-
tionship (p = 0.002) than HIV-uninfected participants.
Based on the results of the MINI-D interview, a greater
proportion of HIV-infected participants (52.9%) were
more likely to be classified as having an MDD than HIV-
uninfected participants (28.7%; p = 0.011). After adjusting
for maternal age and marital status, HIV-infected preg-
nant women scored 6.2 points higher on the CES-D than
HIV-uninfected participants (p = 0.032).
Reliability and validity of the CES-D scale
The internal consistency of the CES-D was high (Cronbach’s
alpha = 0.92). As expected, CES-D scores were higher
among MINI-defined current MDD cases than non-MDD
cases (Figure 1, P <0.001). Furthermore, the CES-D dis-
criminated well between current MDD cases and non-
cases (Figure 2, AUROC = 0.82).
Se, Sp, and PPV at each CES-D score indicated that the
optimum CES-D cutoff score for current MDD was some-
where between 16 and 17 (Additional file 1: Table S1 &
Figure 3). With a cutoff of 16, the corresponding Se, Sp
and PPV values of 79.6%, 75.9%, and 77.2% were obtained.
When a cutoff of 17 was selected, Sp increased by 2.6% to
78.5%, PPV dropped slightly by 0.7% to 76.5%, and Se
drops by 7.1% to 72.7%.
Among HIV-infected participants, selecting a CES-D
score cutoff value of either 16 or 17 did not affect
the estimated prevalence of probable major depression
(58.3%; Figure 4). On the other hand, selecting a cutoff
value of 16 or 17 affected the estimated prevalence of de-
pression among HIV-uninfected women. At the CES-D
cutoff value of 16, the estimated prevalence of probable
major depression was 9.2% higher than results obtained
with the MINI-D (37.9% vs. 28.7%; Figure 4). A cutoff
value of 17, however, provided a result that was much
closer to results from the psychiatric assessment (32.2%
vs. 28.7%; Figure 4).
Discussion
Overall, the interviewer-administered CES-D scale, as
validated in this study, was a reliable and valid in-
strument for screening for prenatal depression among
pregnant women attending ANC services in northern
Uganda.
The high Cronbach’s alpha (0.92) indicated that sub-
jects in this study were consistent in their responses.
This Cronbach value is similar to that reported by the
original author of the self-reported CES-D [23] and is
slightly higher than those reported among other studies
documenting the reliability of interviewer-administered
CES-D scales in other African settings [3,5]. For in-
stance, among patients with tuberculosis (TB) and HIV
in primary care in Zambia, the Cronbach alpha for an
interviewer-administered CES-D was 0.84 [3].
The AUROC, a measure of the accuracy of discrimin-
ating between two groups, was 0.82, allowing us to use
the CES-D to differentiate women with current MDDs
from those without this condition (Figure 2). Our result
is similar to AUROC values reported from CES-D valid-
ation studies conducted among HIV infected persons in
South Africa (AUROC = 0.76; [5]) and TB and HIV
patients in Zambia (AUROC = 0.78; [3]).
Table 1 Characteristics pregnant women participating in the study to validate the Center for Epidemiologic
Studies-Depression (CES-D) scale in northern Uganda, October 2012–December 2012
Variable Estimate Overall (n = 123) HIV- (n = 87) HIV + (n = 36) HIV- vs. HIV + p value
Gestational age at interview, weeks Mean (s.e.) 18.3 (0.36) 18.3 (0.43) 18.5 (0.66) n.s.***
Participant speaks Acholi or Langi % 91.9% 91.9% 91.7% n.s.
Participants’ age, years Mean (s.e.) 24.3 (0.44) 23.3 (0.49) 26.5 (0.76) 0.001
Woman identifies as married or cohabiting % 87.0% 93.1% 71.2% 0.002
Primary or no education % 53.7% 49.4% 63.9% n.s.
Woman identifies as housewife % 50.4% 51.7% 47.2% n.s.
Monthly household income per capita
(in Uganda Shillings)*
Mean (s.e.) 87,005 (9,229) 93,105 (10,991) 72,433 (16,988) n.s.
MINI-defined current major depressive disorder % 35.8% 28.7% 52.9% 0.011
Unadjusted CES-D score Mean (s.e.) 17.1 (1.24) 14.6 (1.42) 23.2 (2.21) 0.001
Adjusted CES-D score** Mean (s.e.) n/a 15.3 (1.44) 21.5 (2.33) 0.032
*At the time the study was done, 1 US Dollar was equivalent to 2,500 Ugandan Shillings.
**Differences in CES-D scores between HIV-infected and -uninfected pregnant women after adjusting for age and marital status.
***n.s. refers to non-significant.
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A highly sensitive test is needed for screening examina-
tions in routine clinical care to identify potential cases,
while a highly specific test is preferred for confirmatory
purposes [30]. Good screening tests are expected to
minimize the number and proportion of false positive
results and, as such, have a high PPV. A test with high PPV
is in part valued, because it reduces the expense and risks
related to further evaluation of false positive tests, especially
in settings with limited resources [30]. We employed a
combination of Se, Sp, and PPV to arrive at the optimum
CES-D cutoff score for probable major depression in our
sample, a value that was between 16 and 17 (Figure 3).
A cutoff score of 16 had a relatively high Se and slightly
higher PPV values than a cutoff score of 17 (Se 79.6% vs.
72.7%, PPV 77.2% vs. 76.5%; Additional file 1: Table S1).
Using a cutoff of 16 in future studies, therefore, may help
maximize the rate of truly positive results, permitting
appropriate classification of a higher proportion of per-
sons that actually have depression. On the other hand, a
cutoff score of 16 had a lower Sp than a cutoff score of 17
(Sp 75.9 vs. 78.5; Additional file 1: Table S1).
As noted above, a CES-D cutoff score of 17 provided a
higher Sp than the cutoff of 16 and, thus, greater ability to
minimize the proportion of false positive cases of probable
major depression. This cutoff also allowed us to attain
prevalence rates that were closer to those identified
through a psychiatrist-administered MINI-D interview.
The CES-D cutoff of 17 resulted in 39.8% of the women
to be classified as having a probable MDD, versus 43.9%
using the cutoff score of 16. The percentage of women
with probable depression at the 17 cutoff value (39.8%)
was much closer to the prevalence of current MDD
Figure 1 Median CES-D scores by psychiatrist diagnosed
current MDD among HIV-infected and -uninfected pregnant
women (n 123) attending antenatal care clinics in northern
Uganda, October 2012–December 2012.
Figure 2 Area under the receiver operating characteristic curve
(AUROC) for CES-D scores for diagnosis of current MDD among
HIV-infected and -uninfected pregnant women (n 123) attending
antenatal care clinics in northern Uganda, October 2012–December
2012.
Se
/S
p/
PP
V 
(%
) 
TOTAL CES-D SCORES 
Figure 3 Sensitivity, specificity, and positive predictive values for
the CES-D by cutoff scores, for diagnosis of current MDD among
HIV-infected and -uninfected pregnant women (n 123) attending
antenatal care clinics in northern Uganda, October 2012–December
2012.
Figure 4 Proportion of the sample classified as probable MDD
cases at CES-D cutoff point of ≥16 or ≥17 in comparison to results
from the psychiatrist diagnosed current MDD among HIV-infected
and -uninfected pregnant women (n 123) attending antenatal
care clinics in northern Uganda, October 2012–December 2012.
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(35.8%) obtained with the MINI-D assessment (Figure 4).
However, as shown in Figure 4, selection of a cutoff score
of 17 appeared most helpful when screening HIV-negative
respondents. Among HIV-positive respondents, the same
percentage of respondents with a probable MDD (58.3%)
was reached irrespective of whether a cutoff of 16 or 17 was
used. Our information, therefore, suggests that using a
cutoff of 17 is appropriate for both HIV-infected and
-uninfected pregnant women, and we plan to adopt this
cutoff for our ongoing study activities and reporting of the
prevalence and incidence of probable major depression in
the PreNAPs cohort.
The cutoff score of 17 for this interviewer adminis-
tered CES-D scale is comparable to the cutoff score of
16 for the self-reported CES-D suggested by Radloff for
the general US population [23]. In contrast, our cutoff
value is much lower than scores obtained with the inter-
viewer-administered CES-D study among HIV and TB
patients in Zambia. In the Zambia study, a cutoff value
of 22 was indicated to have a Se of 73% and PPV value
of 76% when compared to MINI-D outputs [3]. The
higher cutoff value obtained in that study may relate to
the fact that their population, unlike ours that was pre-
dominantly HIV-uninfected, was only composed of HIV
and TB infected participants. Furthermore, the MINI-D
module for our study was administered by a medical
psychiatrist (TOO), and mental health clinical assistants
administered the MINI-D in the Zambia study.
Our data do not support the findings of others in South
Africa [17] and the US [18], where depressive symptoms
do not differ by pregnant women’s HIV status. After
adjusting for maternal age and marital status, HIV-
infected pregnant women in our study scored 6.2 points
higher on the CES-D than HIV uninfected participants
(Table 1, p = 0.032). However, the focus of this study was
on validation of the CES-D instrument, and we caution
against over-interpretation of this finding. We note that
the HIV-infected women may have had adverse life expe-
riences, such as the loss of their partners or family mem-
bers due to HIV, or may have suffered from stigma, and
these factors may be more powerful proximal de-
terminants of differences in CES-D scores than the HIV
infection itself. Given the number of HIV-infected women
(n = 36) compared to HIV-uninfected participants (n = 87)
in this study, we did not have sufficient power to fully test
the hypothesis that HIV-infected women scored higher on
the CES-D than -uninfected participants. In the future,
larger studies will need to examine the hypothesis that
CES-D scores and the prevalence and incidence rate of
depression differ by pregnant women’s HIV-status. Such
studies will also need to adjust for other correlates of de-
pression, in addition to maternal age and marital status,
such as food insecurity and women’s access to different
forms of social support [31].
Our study has some limitations. For one, the gene-
ralizability of our findings may be limited. As noted
above, it is possible that the CES-D performs differently
among HIV-infected and -uninfected pregnant women.
Our data, however, do suggest that an identical cutoff
value of 17 is appropriate for the CES-D screening tool
in both HIV-infected and -uninfected populations. We
also note that the CES-D was administered to women at
about 18 weeks of gestation (Table 1), and we cannot
comment on how the cutoff scoring might have changed
through the entire course of pregnancy. In addition,
although the MINI-D module has been used success-
fully among different subpopulations in Uganda [32-34],
we found no studies that, as recommended by its inven-
tors [24], aimed to validate or culturally adapt it in ways
that go beyond language translation. Furthermore, this
study was done at a higher-level health facility, and
pregnant women attending GRRH may differ from the
general northern Uganda population (in terms of educa-
tion, rural vs. urban residence, access to information,
and other factors), such that our findings may not be
widely generalizable.
In spite of these limitations, these data suggest that the
CES-D as used in the PreNAPs study is a reliable and valid
measure of depressive symptoms in this population. To
expand the applicability of the CES-D within this context,
future studies could assess the reliability and validity of
the CES-D in the general northern Uganda population.
We believe there would be merit in using a relatively large
sample size that can permit separate assessment of the
CES-D screening tool’s reliability and validity among HIV-
infected and -uninfected pregnant women.
In the short term, interventions to mitigate prenatal de-
pression in this vulnerable population are needed, given
the high prevalence of psychiatrist diagnosed major
depression (28.7% among HIV-uninfected, vs. 52.9% in
HIV-infected subgroups) and the likely adverse impacts of
depression on women [19] and their infants [20,21]. Mod-
ifications to current mental health screening policies,
especially among PMTCTattendees, may help with identi-
fication and treatment of depressed pregnant women.
Most Ugandan regional referral hospitals have mental
health departments. However, opportunities for screening,
referral and follow-up of affected patients are usually
missed due to limited staffing, remuneration, motivation,
and retention of skilled health workers. Current national
ANC guidelines are silent about integrating screening for
mental health problems such as depression. The high
prevalence of MDD that we observed in this study sug-
gests the need for revision of existing Ugandan ANC
guidelines to incorporate screening, treatment and referral
of pregnant women for depression. The World Health
Organisation (WHO) recommends integrating mental
health activities into ANC programs [35], and approaches
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for doing this in resource-poor settings have been identi-
fied, for example through the use of WHO mental health
Gap Action Program guidelines [36]. The CES-D is a brief,
valid, and simple screening tool that could be used to
identify pregnant women with or at risk of depression.
Conclusions
The CES-D scale, administered by non-psychiatrists, was
found to be a reliable and valid screening tool in a popula-
tion of women of mixed HIV status receiving ANC, when
compared to a psychiatrist-administered and structured
MINI-D interview. Given the high prevalence (35.8%) of
psychiatrist-diagnosed depression in this population, there
is need to adopt a reliable and valid screening tool for
depression (such as the CES-D), further evaluation, and
the treatment of pregnant women with elevated depressive
symptoms. More research will be needed, however, to
assess the time demands and overall programmatic expe-
rience of integrating care for depression into current ANC
service delivery platforms.
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